Literature DB >> 16648775

The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results.

Tomás Novák1, Jirí Horácek, Pavel Mohr, Miloslav Kopecek, Lucie Skrdlantová, Monika Klirova, Mabel Rodriguez, Filip Spaniel, Colleen Dockery, Cyril Höschl.   

Abstract

The high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the prefrontal cortex is a promising method for the treatment of negative symptoms of schizophrenia. Using double-blind sham-controlled parallel design, we evaluated the effect of HF-rTMS over the left dorsolateral prefrontal cortex (DLPFC) on negative symptoms in patients with schizophrenia. Sixteen schizophrenia patients with predominantly negative symptoms on stable antipsychotic medication were treated with 20 Hz rTMS (90% of motor threshold, 2000 stimuli per session) over ten days within 2 weeks with six weeks follow-up. The effect was assessed using PANSS, CGI, MADRS and neuropsychological tests. We failed to find any significant effect of active rTMS. Sham rTMS showed a trend for improvement over time on positive and negative subscales of PANSS and MADRS. Between-group comparisons failed to reveal any significant differences on any rating scales except a positive subscale of PANSS after 8 weeks. Results from our study did not confirm that HF-rTMS over the left DLPCF affects the negative symptoms of schizophrenia and alternative rTMS approaches are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16648775

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  19 in total

1.  Using Cognitive Neuroscience to Improve Mental Health Treatment: A Comprehensive Review.

Authors:  Jessica A Wojtalik; Shaun M Eack; Matthew J Smith; Matcheri S Keshavan
Journal:  J Soc Social Work Res       Date:  2018-04-27

2.  Neuromodulation Treatments for Schizophrenia.

Authors:  Mehmet E Dokucu
Journal:  Curr Treat Options Psychiatry       Date:  2015-07-03

Review 3.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

Review 4.  Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?

Authors:  Asli Demirtas-Tatlidede; Andrew M Vahabzadeh-Hagh; Alvaro Pascual-Leone
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

5.  Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis.

Authors:  Chuan Shi; Xin Yu; Eric F C Cheung; David H K Shum; Raymond C K Chan
Journal:  Psychiatry Res       Date:  2013-12-21       Impact factor: 3.222

Review 6.  Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date.

Authors:  Jonathan C Cole; Carolyn Green Bernacki; Amanda Helmer; Narsimha Pinninti; John P O'reardon
Journal:  Innov Clin Neurosci       Date:  2015 Jul-Aug

7.  High-frequency prefrontal repetitive transcranial magnetic stimulation for the negative symptoms of schizophrenia: a case series.

Authors:  Arielle D Stanford; Cheryl Corcoran; Peter Bulow; Sarah Bellovin-Weiss; Dolores Malaspina; Sarah H Lisanby
Journal:  J ECT       Date:  2011-03       Impact factor: 3.635

Review 8.  Use of transcranial magnetic stimulation to influence behavior.

Authors:  Benzi M Kluger; William J Triggs
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

Review 9.  Repetitive Noninvasive Brain Stimulation to Modulate Cognitive Functions in Schizophrenia: A Systematic Review of Primary and Secondary Outcomes.

Authors:  Alkomiet Hasan; Wolfgang Strube; Ulrich Palm; Thomas Wobrock
Journal:  Schizophr Bull       Date:  2016-07       Impact factor: 9.306

10.  Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia.

Authors:  Catarina Freitas; Felipe Fregni; Alvaro Pascual-Leone
Journal:  Schizophr Res       Date:  2009-01-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.